Cost‐effectiveness of early noninvasive cardiac testing for suspected acute coronary syndrome
In patients with suspected ACS evaluated in the ED, incorporation of early NIT was associated with an overall increase in cost of health care that was driven by increased cost of the initial ED visit. However, due to the significant clinical benefits, early NIT was cost-effective in the low- and intermediate-risk patients while it is a dominant strategy in high-risk patients saving cost and QALYs.
Authors
- Aniket A. Kawatkar (ORCID: https://orcid.org/0000-0001-6810-6467)
- Adam L. Sharp (ORCID: https://orcid.org/0000-0002-6736-6184)
- Benjamin Sun
- Steve Goodacre (ORCID: https://orcid.org/0000-0003-0803-8444)
- Praveen Thokala (ORCID: https://orcid.org/0000-0003-4122-2366)
- Aileen Baecker (ORCID: https://orcid.org/0000-0003-4739-0870)
- Maros Ferencik (ORCID: https://orcid.org/0000-0001-5872-2223)
- Ming‐Sum Lee (ORCID: https://orcid.org/0000-0001-6121-6452)
- Rita F. Redberg (ORCID: https://orcid.org/0000-0001-6281-0250)
Institutions
- Kaiser Permanente (US)
- Oregon Health & Science University (US)
- University of California, San Francisco (US)
- Los Angeles Medical Center (US)
- Kaiser Permanente West Los Angeles Medical Center (US)
- University of Pennsylvania (US)
- University of Sheffield (GB)
Publication Details
- Journal
- Academic Emergency Medicine
- Published
- 2025-05-24
- DOI
- https://doi.org/10.1111/acem.70066
- Citations
- 2
- Primary Topic
- Acute Myocardial Infarction Research
- Type
- article
- Field-Weighted Citation Impact
- 2.78
Funders
- National Heart, Lung, and Blood Institute